| ACMR |
Advisory Committee on Medical Research (WHO) |
| AD |
Auto-Disable |
| AIDP |
Advanced Development and Introduction Plans |
| ADR |
Adverse Drug Reaction |
| AEFI |
Adverse Events Following Immunization |
| AFP |
Acute Flacid Paralysis |
| AFRO |
WHO Regional Office for Africa |
| AIDS |
Acquired Immunodeficiency Syndrome |
| aP |
Acellular pertussis vaccine |
| ARI |
Acute Respiratory Infections |
| ARV |
Antiretroviral |
| AVI |
Accelerated Vaccine Introduction |
| BCG |
Bacilli Calmette-Guérin |
| CCCCM |
Collaborative Centre on Cold Chain Management |
| CCEM |
Cold Chain Equipment Tool |
| CCL |
Cold Chain and Logistics |
| CDD |
Control of Diarrhoeal Diseases |
| CBR |
Crude Birth Rate |
| CDR |
Crude Death Rate |
| CFC |
Chloro-Fluoro-Carbon |
| CFR |
Case Fatality Rate |
| CVP |
Children’s Vaccine Programme |
| CHW |
Community Health Worker |
| DCVMN |
Developing Country Vaccine Manufacturers’ Network |
| DF |
Deep Freezer |
| DHF |
Dengue haemorrhagic fever |
| Dip |
Diphtheria Vaccine |
| DOTS |
Directly Observed Treatment, (short-course) |
| DT |
Diptheria and tetanus toxoid |
| DTP |
Diphtheria-tetanus-pertussis |
| DTPHep |
Tetravalent diphtheria and tetanus toxoid with pertussis and hepatitis B vaccine |
| DTPHepIPV |
Pentavalent diphtheria and tetanus toxoid with pertussis, hepatitis B and inactivated polio vaccine |
| DTPHH |
Diphtheria and tetanus toxoid with pertussis, hepatitis B, and Hæmophilus influenzæ type b vaccine |
| DTPHib |
Tetravalent diphtheria and tetanus toxoid with pertussis and Hæmophilus influenzæ type b vaccine |
| DTPHibHep |
Pentavalent diphtheria and tetanus toxoid with pertussis, Hæmophilus influenzæ type b and hepatitis B vaccine |
| DTPHibHepIPV |
Hexavalent diphtheria, tetanus toxoid with pertussis, Hæmophilus influenzæ type b, hepatitis B and inactivated polio vaccine |
| DTPHibIPV |
Pentavalent diphtheria and tetanus toxoid with pertussis, Hæmophilus influenzæ type b and inactivated polio vaccine |
| DTwP |
Diphtheria and Tetanus Toxoid with Whole Cell Pertussis Vaccine |
| EEFO |
Earliest-expiry-first-out |
| EIA |
Enzyme Immunoassay |
| EIS |
Epideiological Information System |
| EMRO |
WHO Regional Office for the Eastern Mediterranean |
| EPI |
Extended Programme of Immunization |
| ESARO |
UNICEF Regional Office for East and South Africa |
| EURO |
WHO Regional Office for Europe |
| EVSM |
Effective Vaccine Store Management |
| FIC |
Fully Immunised Child |
| FIFO |
First-In-First-Out |
| GAVI |
Global Alliance for Vaccines and Immunization |
| GIVS |
Global Immunization Vision and Strategy |
| GPV |
WHO Global Programme for Vaccines and Immunization |
| GTN |
Global Training Network |
| HbsAg |
Hepatitis B Surface Antigen |
| HBV |
Hepatitis B Virus |
| HepA |
Hepatitis A Vaccine |
| HepB |
Hepatitis B |
| HI |
Haemagglutination inhibition (test) |
| Hib |
Haemophilus influenzae b |
| HIV |
Human Immunodeficiency Virus |
| HMIS |
Health Management Information System |
| HSR |
Health System Research |
| ICC |
Inter-agency Coordinating Committees |
| IDS |
Integrated Disease Surveillance |
| IFA |
Immunofluorescence Assay |
| IFF |
International Finance Facility |
| IFPMA |
International Federation of Pharmaceutical Manufacturers’ Associations |
| IHR |
International Health Regulations |
| ILR |
Ice-lined Refrigerator |
| IMR |
Infant Mortality Rate |
| IPT |
Intermittent Preventive Treatment |
| IPTi |
Intermittent Preventive Treatment for Children |
| IPTi |
Intermittent Preventive Treatment for Infants |
| IPV |
Inactivated Polio Vaccine |
| ISO |
International Standards Organization |
| ITF |
Immunisation Task Force |
| IVB |
Immunization, Vaccines and Biologicals |
| ITN |
Insecticide-Treated Nets |
| JE |
Japanese Encephalitis |
| JRF |
WHO/UNICEF Joint Reporting Form |
| KAP |
Knowledge, Attitudes, and Practices |
| MCV |
Measles-Containing Vaccine |
| MDVP |
Multidose Vial policy |
| MenAC |
Meningococcal AC vaccine |
| MLM |
Mid Level Management (Course) |
| MM |
Measles and Mumps Vaccine |
| MMR |
Mumps-Measles-Rubella |
| MNT |
Maternal and Neonatal Tetanus |
| MOH |
Ministry Of Health |
| MR |
Measles-Rubella |
| NID |
National Immunization Day |
| NIP |
National Immunization Programme |
| NRA |
National Regulatory Authority |
| NT |
Neonatal Tetanus |
| NVS |
New and Under-used Vaccine Support |
| OPV |
Oral polio vaccine |
| Pa |
Acellular pertussis vaccine |
| PAB |
Protection At Birth |
| PAHO |
Pan American Health Organization |
| PATH |
Program for Appropriate Technology in Health |
| PCR |
polymerase chain reaction |
| PCV |
Pneumococcal Conjugated Vaccine |
| PHC |
Primary Health Care |
| PIS |
product information sheets |
| PIS |
WHO/UNICEF product information sheets |
| Pneumo_ps |
pneumococcal polysaccharide vaccine |
| PPV |
Pneumococcal Polysaccharide Vaccine |
| PRV |
Pentavalent Rotavirus Vaccine |
| Pw |
Whole-cell pertussis vaccine |
| RBM |
Roll Back Malaria |
| RED |
Reaching Every District |
| RT-PCR |
Reverse transcription / polymerase chain reaction |
| SAGE |
Strategic Advisory Group of Experts (WHO) |
| SEARO |
WHO Regional Office for South-East Asia |
| SIA |
Supplemental Immunization Activity |
| SNIDS |
Sub-national Immunization Days |
| SRS |
Severe Acute Respiratory Syndrome |
| STD |
Sexually Transmitted Diseases |
| SWAp |
Sector Wide Approach |
| TB |
Tuberculosis |
| Td |
Tetanus toxoid with reduced amount of diphtheria toxoid vaccine |
| TT |
Tetanus Toxoid |
| VAR |
Vaccine Arrival Report |
| VF |
Vaccine Fund |
| VPD |
Vaccine Preventable Disease |
| VPM |
Vaccine Product Menu |
| VPPAG |
Vaccine Packaging and Presentation Advisory Group |
| VVC |
Vaccine Volume Calculator |
| VVM |
Vaccine Vial Monitor |
| WHO |
World Health Organization |
| wP |
Whole cell pertussis vaccine |
| WPRO |
WHO Regional Office for the Western Pacific |
| YF |
Yellow fever |
| |
|
